CASI — CASI Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for CASI Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	66.4	48.6	49.9	18.8	16.1
Net Total Accounts Receivable
Net Total Receivables	4.64	9.8	13	10.1	15.3
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	74	62	73.4	59.3	39.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10.8	21.8	13.2	11.6	11.4
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	128	138	96.2	75.3	53.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7.98	13.2	17	16.7	36.5
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	46.2	53.8	51.7	51.1	51.8
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	81.5	84.5	44.6	24.2	1.85
Total Liabilities & Shareholders' Equity	128	138	96.2	75.3	53.7
Total Common Shares Outstanding
Total Preferred Shares Outstanding